Filed before 2025Filed 18 November 2022
NovoGlia, Inc. raised $24.3M
NovoGlia, Inc., a biotech company based in Aliso Viejo, CA, raised $24.3M in a new equity round, according to a filing dated 18 November 2022.
Raises filed before 2025 are not checked for a public announcement.
- Filed
- 18 November 2022
- Round
- Equity round
- Amount sold
- $24.3M
- Offering size
- $54.3M
- Investors so far
- 54
- Based in
- Aliso Viejo, CA
Investors on the board
Firms come from the venture funds whose filings name a director of this company.
Who is on the board
1 director of this company is named on venture funds' filings. Sign in free with Google to see who, the full filing, and a short list of rounds like this each morning.
Sign in with GoogleHow it compares
Larger than 75% of the 1,764 tracked raises with an amount filed in 2022, and than 73% of the 142 in biotech.
Savanna Biotherapeutics, Inc. in public filings
| Filed | Filing | Sold | Raise |
|---|---|---|---|
| 30 Jun 2025 | New filing | $13M | Another raise |
| 18 Nov 2022 | New filing | $24.3M | This raise |
More with Bluebird Ventures on the board
- Forty Seven, Inc.$75M
- Merganser Biotech, Inc.$13.1M
- Theracos Inc$25M
- Virobay Inc$18M
Other unannounced rounds
- DVx Atomic Co.$18.5M
- Aperio Systems, Inc.$1.6M
- Twin Health, Inc.$59M
- Scoring Factory AI Inc.$500K
- Royal & Pelham, Inc.$5.4M
- SPECTRA Holdings US, Ltd.$2.5M
Seen it announced?
Send the link and the check will look at it.